ASX - By Stock
|
AVR |
Re:
Interview on the Market Herald with Wayne.
|
|
platinumstandard
|
78 |
25K |
4 |
25/01/21 |
25/01/21 |
ASX - By Stock
|
78
|
25K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Interview on the Market Herald with Wayne.
|
|
platinumstandard
|
78 |
25K |
4 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
78
|
25K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Interview on the Market Herald with Wayne.
|
|
platinumstandard
|
78 |
25K |
9 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
78
|
25K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Interview on the Market Herald with Wayne.
|
|
platinumstandard
|
78 |
25K |
7 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
78
|
25K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Interview on the Market Herald with Wayne.
|
|
platinumstandard
|
78 |
25K |
1 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
78
|
25K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Interview on the Market Herald with Wayne.
|
|
platinumstandard
|
78 |
25K |
0 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
78
|
25K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Interview on the Market Herald with Wayne.
|
|
platinumstandard
|
78 |
25K |
6 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
78
|
25K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Interview on the Market Herald with Wayne.
|
|
platinumstandard
|
78 |
25K |
3 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
78
|
25K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Interview on the Market Herald with Wayne.
|
|
platinumstandard
|
78 |
25K |
4 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
78
|
25K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Funding Package
|
|
platinumstandard
|
91 |
25K |
4 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
91
|
25K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Research and Development Advance
|
|
platinumstandard
|
31 |
7.2K |
1 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
31
|
7.2K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Research and Development Advance
|
|
platinumstandard
|
31 |
7.2K |
3 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
31
|
7.2K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Research and Development Advance
|
|
platinumstandard
|
31 |
7.2K |
5 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
31
|
7.2K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Research and Development Advance
|
|
platinumstandard
|
31 |
7.2K |
5 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
31
|
7.2K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Research and Development Advance
|
|
platinumstandard
|
31 |
7.2K |
4 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
31
|
7.2K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Research and Development Advance
|
|
platinumstandard
|
31 |
7.2K |
2 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
31
|
7.2K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Placement
|
|
platinumstandard
|
48 |
11K |
6 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
48
|
11K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Placement
|
|
platinumstandard
|
48 |
11K |
0 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
48
|
11K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Placement
|
|
platinumstandard
|
48 |
11K |
1 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
48
|
11K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Placement
|
|
platinumstandard
|
48 |
11K |
6 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
48
|
11K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Suspension from Official Quotation
|
|
platinumstandard
|
32 |
9.5K |
5 |
29/12/20 |
29/12/20 |
ASX - By Stock
|
32
|
9.5K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Suspension from Official Quotation
|
|
platinumstandard
|
32 |
9.5K |
4 |
29/12/20 |
29/12/20 |
ASX - By Stock
|
32
|
9.5K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: TAVR Medical Advisory Board Appointment
|
|
platinumstandard
|
11 |
3.3K |
0 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
11
|
3.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anti-calcification Comparison Study Interim Results
|
|
platinumstandard
|
96 |
23K |
4 |
14/11/20 |
14/11/20 |
ASX - By Stock
|
96
|
23K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
platinumstandard
|
14 |
4.4K |
2 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
14
|
4.4K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR valve patient outcomes exceed expectations
|
|
platinumstandard
|
65 |
16K |
2 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
65
|
16K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR valve patient outcomes exceed expectations
|
|
platinumstandard
|
65 |
16K |
3 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
65
|
16K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR valve patient outcomes exceed expectations
|
|
platinumstandard
|
65 |
16K |
2 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
65
|
16K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Aortic Vale publications form Berlin and Munich Hospitals
|
|
platinumstandard
|
56 |
12K |
4 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
56
|
12K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Aortic Vale publications form Berlin and Munich Hospitals
|
|
platinumstandard
|
56 |
12K |
5 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
56
|
12K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Aortic Vale publications form Berlin and Munich Hospitals
|
|
platinumstandard
|
56 |
12K |
8 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
56
|
12K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Operations update
|
|
platinumstandard
|
106 |
28K |
3 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
106
|
28K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Operations update
|
|
platinumstandard
|
106 |
28K |
0 |
16/09/20 |
16/09/20 |
ASX - By Stock
|
106
|
28K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Operations update
|
|
platinumstandard
|
106 |
28K |
4 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
106
|
28K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Unusual Trading Patterns
|
|
platinumstandard
|
214 |
59K |
1 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
214
|
59K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Unusual Trading Patterns
|
|
platinumstandard
|
214 |
59K |
3 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
214
|
59K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Unusual Trading Patterns
|
|
platinumstandard
|
214 |
59K |
2 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
214
|
59K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Unusual Trading Patterns
|
|
platinumstandard
|
214 |
59K |
5 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
214
|
59K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Medtronic's - What their experts have to say about AS and TAVR
|
|
platinumstandard
|
6 |
1.9K |
1 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
6
|
1.9K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Unusual Trading Patterns
|
|
platinumstandard
|
214 |
59K |
0 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
214
|
59K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Unusual Trading Patterns
|
|
platinumstandard
|
214 |
59K |
5 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
214
|
59K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Unusual Trading Patterns
|
|
platinumstandard
|
214 |
59K |
6 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
214
|
59K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Unusual Trading Patterns
|
|
platinumstandard
|
214 |
59K |
5 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
214
|
59K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Unusual Trading Patterns
|
|
platinumstandard
|
214 |
59K |
3 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
214
|
59K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Credit Suisse Research Report
|
|
platinumstandard
|
60 |
15K |
0 |
03/08/20 |
03/08/20 |
ASX - By Stock
|
60
|
15K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Unusual Trading Patterns
|
|
platinumstandard
|
214 |
59K |
5 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
214
|
59K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
platinumstandard
|
29 |
9.1K |
3 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
29
|
9.1K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Interview with CEO Wayne Paterson re: 2020 milestones
|
|
platinumstandard
|
34 |
7.4K |
4 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
34
|
7.4K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AVR host TAVR KOL Symposium moderated by Credit Suisse
|
|
platinumstandard
|
28 |
5.8K |
7 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
28
|
5.8K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AVR host TAVR KOL Symposium moderated by Credit Suisse
|
|
platinumstandard
|
28 |
5.8K |
0 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
28
|
5.8K
|
0
|
|